Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Perceptive Advisors LLC's stake in Acrivon Therapeutics, Inc. fell below 5% (Schedule 13G/A)
Event Jun 2, 2025 · Filed Jun 4, 2025
Perceptive Advisors LLC's stake in Acrivon Therapeutics, Inc. fell below 5%, 0 shares, as a passive investor on Jun 2, 2025. Filed Jun 4, 2025 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 0% | 0 |
| Joseph Edelman | 0% | 0 |
| Perceptive Life Sciences Master Fund, Ltd. | 0% | 0 |
Source
Related
- Acrivon Therapeutics, Inc.
- Perceptive Advisors LLC
- Acrivon Therapeutics, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · May 1, 2025
- Form 4 · Miller Mary · Oct 7, 2026
- Form 4 · Levin Michaela · Sep 2, 2026
- Form 4 · Blume-Jensen Peter · Aug 27, 2026
- Form 4 · Peterson Katharine · Aug 20, 2026
- Form 4 · Miller Mary · Aug 20, 2026